Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Saccharin

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Saccharin?

Saccharin is an investigational drug.

There have been 8 clinical trials for Saccharin. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2013.

The most common disease conditions in clinical trials are Hyperglycemia, Sinusitis, and Sclerosis. The leading clinical trial sponsors are National Cardiovascular Center Harapan Kita Hospital Indonesia, Osypka Germany, and Dalim BioTech Co., Ltd.

There is one US patent protecting this investigational drug and fifteen international patents.

Recent Clinical Trials for Saccharin
Betadine Rinses for Chronic Rhinosinusitis Prospective Cohort StudySt. Paul's Hospital, CanadaEarly Phase 1
Congenital CMV and Hearing Loss in Children up to 4 Years of Age: Treating With Valganciclovir TherapyUniversity of Alabama at BirminghamPhase 2
Efficacy Study of Folic Acid Supplementation in Adolescent EpilepticsMaharashtra University of Health SciencesPhase 3

See all Saccharin clinical trials

Clinical Trial Summary for Saccharin

Top disease conditions for Saccharin
Top clinical trial sponsors for Saccharin

See all Saccharin clinical trials

US Patents for Saccharin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Saccharin   Start Trial Halogen-substituted heterocyclic compound UBE INDUSTRIES, LTD. (Ube-Shi, JP)   Start Trial
Saccharin   Start Trial Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors Forma Therapeutics, Inc. (Watertown, MA)   Start Trial
Saccharin   Start Trial Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same Duquesne University of the Holy Spirit (Pittsburgh, PA)   Start Trial
Saccharin   Start Trial Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same Protalix Ltd. (Carmiel, IL)   Start Trial
Saccharin   Start Trial Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus Seattle Genetics, Inc. (Bothell, WA)   Start Trial
Saccharin   Start Trial Composition for structural adhesive JACRET (Le Thillay, FR)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Saccharin

Drugname Country Document Number Estimated Expiration Related US Patent
Saccharin Australia 2013366898 2032-12-28   Start Trial
Saccharin Brazil 112015015275 2032-12-28   Start Trial
Saccharin Canada 2896701 2032-12-28   Start Trial
Saccharin China 104884447 2032-12-28   Start Trial
Saccharin China 107698555 2032-12-28   Start Trial
Saccharin Denmark 2940013 2032-12-28   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.